Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate Read more →

Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024 Read more →

FDA’s rare pediatric disease voucher program revived by 2026 government funding bill Read more →